<DOC>
	<DOCNO>NCT00193011</DOCNO>
	<brief_summary>This trial evaluate effectiveness standard adjuvant treatment CMF chemotherapy versus treatment weekly docetaxel patient high-risk breast cancer 65 year age old poor candidate anthracycline-containing regimen . This CMF regimen decrease dose intensity may slightly less active patient metastatic breast cancer ; however , patient population trial tolerate intensive CMF regimens poorly trial .</brief_summary>
	<brief_title>Weekly Docetaxel CMF Adjuvant Treatment Elderly Women With High-Risk Breast Cancer</brief_title>
	<detailed_description>Upon determination eligibility , patient randomly assign one two treatment arm : - Docetaxel - Cyclophosphamide + Methotrexate + 5-fluorouracil This blind study patient investigator know treatment assign . Chemotherapy follow breast and/or regional radiotherapy appropriate patient , hormone therapy tamoxifen 5 year patient estrogen-receptor positive . Patients consider poor candidate receive tamoxifen may receive hormonal therapy anastrazole .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>To include study , must meet following criterion : Female patient adenocarcinoma breast confirm biopsy Age 65 old Under age 65 must significant medical illness , general frailty Adequate bone marrow , liver kidney function Normal heart function Less 84 day mastectomy/lumpectomy axillary dissection Signed consent obtain prior initiation study procedure You participate study follow apply : Received neoadjuvant therapy Primary tumor locally advanced diagnosis Received prior chemotherapy within five year Received previous radiation therapy within 5 year Peripheral neuropathy Please note : There additional inclusion/exclusion criterion . The study center determine meet criterion . If qualify trial , study personnel explain reason . If qualify , study personnel explain trial detail answer question may .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>